Murine Model for Therapy of Listeriosis in the Compromised Host
- 1 January 1981
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 27 (3), 214-219
- https://doi.org/10.1159/000237980
Abstract
Therapy of listeriosis with ampicillin was examined in two murine models with compromised defense mechanisms. In mice treated with dextran sulfate paralysing the function of the macrophage system, ampicillin was less able to reduce death rates as well as bacterial counts in the spleens than after infection of normal mice. In nude mice with chronic listeriosis, treatment with ampicillin was started 8 days after infection. The numbers of viable listeria cells decreased under therapy, but a bacteriologic cure was not achieved in a 6-day schedule. Relapse followed cessation of therapy.Keywords
This publication has 8 references indexed in Scilit:
- Response to Therapy in an Experimental Rabbit Model of Meningitis Due to Listeria monocytogenesThe Journal of Infectious Diseases, 1979
- Antibiotic Susceptibility of Clinical Isolates of Listeria monocytogenesAntimicrobial Agents and Chemotherapy, 1978
- Rifampicin against Experimental Listeriosis in the MouseChemotherapy, 1978
- Listeria cerebritis: relapse of infection in renal transplant patientsArchives of Internal Medicine, 1978
- Cell-mediated resistance to infection with Listeria monocytogenes in nude miceInfection and Immunity, 1977
- Listeriosis Complicating Malignant DiseaseAnnals of Internal Medicine, 1967
- Antibiotic Susceptibility of Listeria Monocytogenes and Treatment of Neonatal Listeriosis with AmpicillinActa Paediatrica, 1967
- ANTIBIOTIC SUSCEPTIBILITY TESTING BY A STANDARDIZED SINGLE DISK METHOD1966